Please enable JS

Healthcare

Title Published Pages Region Price
Global Japanese Encephalitis Vaccine Industry 2016 Market Research Report Mar 31 2016 151 Global $2,800.00
United States Blood Glucose Meters Industry 2016 Market Research Report Mar 31 2016 135 USA $3,800.00
United States Body Composition Analyzers Industry 2016 Market Research Report Mar 31 2016 138 USA $3,800.00
United States Capillaroscopes Industry 2016 Market Research Report Mar 31 2016 133 USA $3,800.00
United States Ophthalmoscopes Industry 2016 Market Research Report Mar 31 2016 137 USA $3,800.00
United States Physical Activity Monitors Industry 2016 Market Research Report Mar 31 2016 132 USA $3,800.00
United States Sterile Medical Packaging Industry 2015 Market Research Report Mar 31 2016 148 USA $3,800.00
Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift Towards Targeted mAbs Mar 10 2016 70 Global $6,995.00
EpiCast Report: Bipolar Disorder - Epidemiology Forecast to 2024 Mar 1 2016 64 Global $3,995.00
Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies Mar 1 2016 64 Global $2,995.00
Asthma Therapeutics in Asia-Pacific Markets to 2021 - High Prevalence and Launch of Late-Stage Biologics will Drive the Market in Spite of Affordability Concerns Mar 1 2016 130 Asia Pacific $4,995.00
Alzheimer’s Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Disease Modifying Therapies Mar 1 2016 151 Asia Pacific $4,995.00
PharmaPoint: Bipolar Disorder - Global Drug Forecast and Market Analysis to 2024 Mar 1 2016 440 Global $10,995.00
Bipolar Disorder - Current and Future Players Mar 1 2016 105 Global $2,995.00
Bipolar Disorder - Canada Drug Forecast and Market Analysis to 2024 Mar 1 2016 312 Canada $4,995.00
Bipolar Disorder - Japan Drug Forecast and Market Analysis to 2024 Mar 1 2016 313 Japan $4,995.00
Bipolar Disorder - US Drug Forecast and Market Analysis to 2024 Mar 1 2016 313 USA $4,995.00
Bipolar Disorder - 5EU Drug Forecast and Market Analysis to 2024 Mar 1 2016 313 Europe $6,995.00
Frontier Pharma: Breast Cancer - First-in-Class Innovation Clustered Around Growth Factor Signalling Processes Feb 16 2016 79 Global $6,995.00
Parkinson’s Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments Feb 11 2016 136 Global $4,995.00
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence Feb 4 2016 171 Asia Pacific $4,995.00
EpiCast Report: Head and Neck Cancers - Epidemiology Forecast to 2024 Feb 1 2016 80 Global $3,995.00
Alzheimer’s Disease Therapeutics in Major Developed Markets to 2021 - Aging Population and Improved Disease Understanding Increase Demand for Disease Modifying Agents Feb 1 2016 144 Global $4,995.00
Hepatitis B Virus (HBV) Therapeutics - Current and Future Players Jan 15 2016 84 Global $2,995.00
Hepatitis B Virus (HBV) Therapeutics - US Drug Forecast and Market Analysis to 2024 Jan 15 2016 209 USA $4,995.00
Hepatitis B Virus (HBV) Therapeutics - Japan Drug Forecast and Market Analysis to 2024 Jan 15 2016 209 Japan $4,995.00
Hepatitis B Virus (HBV) Therapeutics - China Drug Forecast and Market Analysis to 2024 Jan 15 2016 210 China $4,995.00
Hepatitis B Virus (HBV) Therapeutics - 5EU Drug Forecast and Market Analysis to 2024 Jan 15 2016 210 Europe $6,995.00
OpportunityAnalyzer: B-Cell Non-Hodgkin’s Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024 Jan 1 2016 282 Global $9,495.00
OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) - Opportunity Analysis and Forecasts to 2024 Jan 1 2016 289 Global $9,495.00

Pages